Aging
Navigate
Research Paper|Volume 7, Issue 9|pp 616—628

Geroprotectors.org: a new, structured and curated database of current therapeutic interventions in aging and age-related disease

Alexey Moskalev1,2,3,4, Elizaveta Chernyagina2, João Pedro de Magalhães5,15, Diogo Barardo5, Harikrishnan Thoppil5, Mikhail Shaposhnikov1, Arie Budovsky6,16, Vadim E. Fraifeld6, Andrew Garazha2,7, Vasily Tsvetkov2,8, Evgeny Bronovitsky9, Vladislav Bogomolov2, Alexei Scerbacov10, Oleg Kuryan10,11, Roman Gurinovich10,11, Leslie C. Jellen7,12, Brian Kennedy13, Polina Mamoshina7,15, Evgeniya Dobrovolskaya1, Alex Aliper7,14,15, Dmitry Kaminsky15, Alex Zhavoronkov7,14,15
  • 1Laboratory of Molecular Radiobiology and Gerontology, Institute of Biology of Komi Science Center of Ural Branch of Russian Academy of Sciences, Syktyvkar 167982, Russia
  • 2Moscow Institute of Physics and Technology, Dolgoprudny 141700, Russia
  • 3Laboratory of postgenomic studies, Engelhardt Institute of Molecular Biology of Russian Academy of Sciences, Moscow 119991, Russia
  • 4School of Systems Biology, George Mason University, Manassas, VA 20110, USA
  • 5Integrative Genomics of Ageing Group, Institute of Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK
  • 6The Shraga Segal Department of Microbiology, Immunology, and Genetics, Center for Multidisciplinary Research on Aging, Ben-Gurion University of the Negev, Beer Sheva, Israel
  • 7Insilico Medicine, Inc., ETC, Johns Hopkins University, B301, Baltimore, MD 21218, USA
  • 8The Research Institute for Translational Medicine, Pirogov Russian National Research Medical University, Moscow 117997, Russia
  • 9Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka 142432, Russia
  • 10Xpansa, Conzl OU, Tallinn 10616, Estonia
  • 11Infinity Sciences, Inc, Lewes, DE 19958, USA
  • 12Genetics, Genomics, and Informatics, University of Tennessee Health Science Center, Memphis, TN 38163, USA
  • 13Buck Institute for Research on Aging, Novato, CA 94945, USA
  • 14D. Rogachev Center for Pediatric Hematology, Oncology and Immunology, Moscow, Russia
  • 15The Biogerontology Research Foundation, London, UK
  • 16The Judea Regional R&D Center, Carmel, Israel
Received: June 28, 2015Accepted: August 23, 2015Published: September 2, 2015

Copyright: © 2015 Moskalev et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

As the level of interest in aging research increases, there is a growing number of geroprotectors, or therapeutic interventions that aim to extend the healthy lifespan and repair or reduce aging-related damage in model organisms and, eventually, in humans. There is a clear need for a manually-curated database of geroprotectors to compile and index their effects on aging and age-related diseases and link these effects to relevant studies and multiple biochemical and drug databases. Here, we introduce the first such resource, Geroprotectors (http://geroprotectors.org). Geroprotectors is a public, rapidly explorable database that catalogs over 250 experiments involving over 200 known or candidate geroprotectors that extend lifespan in model organisms. Each compound has a comprehensive profile complete with biochemistry, mechanisms, and lifespan effects in various model organisms, along with information ranging from chemical structure, side effects, and toxicity to FDA drug status. These are presented in a visually intuitive, efficient framework fit for casual browsing or in-depth research alike. Data are linked to the source studies or databases, providing quick and convenient access to original data. The Geroprotectors database facilitates cross-study, cross-organism, and cross-discipline analysis and saves countless hours of inefficient literature and web searching. Geroprotectors is a one-stop, knowledge-sharing, time-saving resource for researchers seeking healthy aging solutions.